One important risk factor for cardiovascular disease is the metabolic syndrome (MS), yet
limited data exist on its prevalence in US patients with schizophrenia. METHODS: Using …

OBJECTIVE: Research has implicated dysfunction of glutamatergic neurotransmission in
the pathophysiology of schizophrenia. This review evaluates evidence from preclinical and …

OBJECTIVE: The goal of this 5-year naturalistic study of patients treated with clozapine was
to examine the incidence of treatment-emergent diabetes mellitus in relation to other factors, …

Background Schizophrenia is characterized by small reductions in cortical gray matter
volume, particularly in the temporal and prefrontal cortices. The question of whether cortical …

Objective The authors' goal was to study the relationship between smoking status and clinical
characteristics in schizophrenic patients. Method Seventy-eight schizophrenic outpatients …

Persons diagnosed with schizophrenia have higher morbidity and mortality rates from
cardiovascular disease, yet often have limited access to appropriate primary care screening or …

OBJECTIVE: Standardized mortality rates are elevated in schizophrenia compared to the
general population. The incidence of coronary heart disease (CHD) and the relative …

Importance To date, the association of psychiatric diagnoses with mortality in patients infected
with coronavirus disease 2019 (COVID-19) has not been evaluated. Objective To assess …

Poor attention and impaired memory are enduring and core features of schizophrenia. These
impairments have been attributed either to global cortical dysfunction or to perturbations of …

Background: Working memory (WM) deficits in schizophrenia have been associated with
dorsolateral prefrontal cortex (DLPFC) dysfunction in neuroimaging studies. We previously …